![John Hampton Griffin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Hampton Griffin was the founder of Numerate, Inc., founded in 2007, where the title held was Secretary.
Dr. Griffin is also the founder of Innoviva, Inc...
Dr. Griffin worked as an Assistant Professor at Stanford University.
Dr. Griffin worked as Chief Scientific Officer at Pharmix Corp.
Dr. Griffin completed undergraduate education at Hope College.
Dr. Griffin earned a doctorate from California Institute of Technology.
| Sociétés | Poste | Fin |
|---|---|---|
Pharmix Corp.
 Pharmix Corp. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals | Directeur Technique/Scientifique/R&D | 13/02/2008 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| INNOVIVA, INC. | Fondateur | - |
Numerate, Inc.
 Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmix Corp.
Pharmix Corp. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals | Health Technology |
Numerate, Inc.
Numerate, Inc. Packaged SoftwareTechnology Services Develops drug engineering platform | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
